https://scholars.lib.ntu.edu.tw/handle/123456789/196856
標題: | Puerperal Lactation Suppression by Metergoline Versus Bromocriptione Metergoline 與 Bromocriptione 在產後泌乳之抑制 |
作者: | LIN, HO-HSIUNG SU, YI-NING WEI, LIN- HUNG HUANG, SU-CHENG 林鶴雄 蘇怡寧 魏凌鴻 黃思誠 |
公開日期: | 1997 | 卷: | v.36 | 期: | n.3 | 起(迄)頁: | 91-94 | 來源出版物: | TAIWANESE JOURNAL OF OBSTETRICS AND GYNECOLOGY | 摘要: | Objective: To compare the efficacy of puerperal lactation suppression by metergoline versus bro-mocriptine. Methods: A prospective, randomized clinical trial of patients with puerperal lactation suppression. Eighty- three parturients were recruited and randomly divided into 4 groups. Group A1 consisted of 24 normal spontaneous delivery cases treated by metergoline and group A2 was 18 cesarean de-livery cases treated by metergoline. Another 23 normal spontaneous delivery cases (group B1) and 18 cesarean delivery cases ( group B2) were treated by bromocriptine. The clinical assessment dur-ing and after medication included the status of inhibition of breast milk secretion, breast engorge-ment and pain as well as the presence of side-effects. In addition, paired serum samples of prolac-tin levels before medication and the third day after medication ( the day of discharge) were meas-ured and the suppression rate of the prolactin level in each case was determined. Results: The mean age, parity and pre-treatment p rolactin level were not statistically significant among the four groups. In contrast, the suppression rate of the prolactin level by bromocriptine was statistically greater than that by metergoline (89% vs. 83%, p< 0.05). However, the clinical as -sessment of lactation inhibition was excellent in each case , and no patients showed any obvious side-effects during follow-up. Conclusions: Both drugs were effective in puerperal lactation suppression and clinical assess-ment of their lactation inhibition was good. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/93845 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。